Shire CEO: Mydayis To Be Big ADHD Drug, But No Ex-US Launch Planned (Yet)

 
• By Sten Stovall
ADHD
Shire CEO says resurrection of SHP465 part of plan to boost neuroscience revenues • Source: Shutterstock

More from New Products

More from Scrip